Authors:
Pilepich, MV
Winter, K
John, MJ
Mesic, JB
Sause, W
Rubin, P
Lawton, C
Machtay, M
Grignon, D
Citation: Mv. Pilepich et al., Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate, INT J RAD O, 50(5), 2001, pp. 1243-1252
Authors:
Lawton, CA
Winter, K
Murray, K
Machtay, M
Mesic, JB
Hanks, GE
Coughlin, CT
Pilepich, MV
Citation: Ca. Lawton et al., Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate, INT J RAD O, 49(4), 2001, pp. 937-946
Authors:
Fisher, J
Scott, C
Stevens, R
Marconi, B
Champion, L
Freedman, GM
Asrari, F
Pilepich, MV
Gagnon, JD
Wong, G
Citation: J. Fisher et al., Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoingbreast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13, INT J RAD O, 48(5), 2000, pp. 1307-1310
Citation: M. Roach et al., Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on radiation therapy oncology group clinical trials (vol 47, pg 609, 2000), INT J RAD O, 48(1), 2000, pp. 313-313
Citation: M. Roach et al., Predicting long-term survival, and the need for hormonal therapy: A meta-analysis of RTOG prostate cancer trials (vol 47, pg 617, 2000), INT J RAD O, 48(1), 2000, pp. 313-313
Authors:
Roach, M
Lu, JD
Pilepich, MV
Asbell, SO
Mohuidden, M
Terry, R
Grignon, D
Citation: M. Roach et al., Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on radiation therapy oncology group clinical trials, INT J RAD O, 47(3), 2000, pp. 609-615
Authors:
Roach, M
Lu, JD
Pilepich, MV
Asbell, SO
Mohuidden, M
Terry, R
Grignon, D
Lawton, C
Shipley, W
Cox, J
Citation: M. Roach et al., Predicting long-term survival, and the need for hormonal therapy: A meta-analysis of RTOG prostate cancer trials, INT J RAD O, 47(3), 2000, pp. 617-627
Citation: Bw. Corn et al., Does androgen suppression enhance the efficacy of postoperative irradiation? A secondary analysis of RTOG 85-31, UROLOGY, 54(3), 1999, pp. 495-502
Authors:
Roach, M
Lu, JD
Pilepich, MV
Asbell, SO
Mohiuddin, M
Terry, R
Grignon, D
Citation: M. Roach et al., Long-term survival after radiotherapy alone: Radiation therapy oncology group prostate cancer trials, J UROL, 161(3), 1999, pp. 864-868